Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2003
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1189916B1 N-pyrazole a 2a receptor agonists
12/10/2003EP1117403B1 Mglur5 antagonists for the treatment of pain and anxiety
12/10/2003EP1056710B1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0932618B1 Peptide analogues containing a 7-membered lactam ring
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003EP0724456B1 Antibodies to cd40
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1460512A Water-soluble propolis liquor and its preparation method
12/10/2003CN1460494A Liquid medicine for external application for making foot therapy
12/10/2003CN1460470A Dichlofenac sodium slow-releasing preparation and its preparation method
12/10/2003CN1460469A Preparation method of aspirin microsphere
12/10/2003CN1130372C 肽衍生物 Peptide derivatives
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/10/2003CN1130220C Chinese medicine 'Ershefengshiwan'
12/10/2003CN1130213C Chinese herbal plaster for anti-canser and analgesic
12/10/2003CN1130201C Synergistic gold-containing compositions
12/09/2003US6660848 Signal Transducer and Activator of Transcription (STAT) proteins are a new class of intracellular transcription factors
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660745 Phosphodiesterase inhibitors; treatment of asthma, chronic obstructive pulmonary disease, inflammatory disorders
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/09/2003US6660525 Therapeutic liposome composition and method
12/09/2003US6660268 Proteasome regulation of NF-KB activity
12/09/2003US6660252 Low emulsifier multiple emulsions
12/09/2003US6659282 Antiinflammatory lipoxing derivatives
12/09/2003CA2227298C Paroxetine controlled release compositions
12/09/2003CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
12/09/2003CA2140247C Novel vitamin d analogues
12/09/2003CA2123697C Novel substituted salicylic acids
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003099845A2 Fas peptide mimetics and uses thereof
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099813A1 Novel physiolgically active substances
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099809A1 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY α4 INTEGRINS
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099788A1 Piperidine derivatives
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099764A1 ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
12/04/2003WO2003099763A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
12/04/2003WO2003099339A1 Decoy composition for treating and preventing inflammatory disease
12/04/2003WO2003099334A1 Topically applicable pharmaceutical preparation
12/04/2003WO2003099323A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
12/04/2003WO2003099317A1 Novel uses of cephaibols
12/04/2003WO2003099305A1 Composition containing an ethyl acetate soluble extract from kalopanax pictus nakai and kalopanaxsaponin a derivatives isolated therein for protecting and treating inflammatory and rheumatic disease
12/04/2003WO2003099302A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
12/04/2003WO2003099301A1 Formulation containing tetrodotoxin for abstinence and analgecize which is administered through respiratory tract
12/04/2003WO2003099289A2 Compositions and their uses for alleviating pain
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099278A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
12/04/2003WO2003099270A1 Methods of treating allergic reactions
12/04/2003WO2003099231A2 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
12/04/2003WO2003099226A2 Antibody peg positional isomers, compositions comprising same, and use thereof
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099195A2 Immunomodulatory compounds and methods of use thereof
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003099011A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
12/04/2003WO2003090818A3 Drug-delivery endovascular stent and method for treating restenosis
12/04/2003WO2003086309A3 NF-κB INHIBITORS
12/04/2003WO2003082196A3 Combination therapy using trefoil peptides
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003064596A3 Desaturase genes, enzymes encoded thereby, and uses thereof
12/04/2003WO2003063794A3 2,4-pyrimidinediamine compounds and their uses
12/04/2003WO2003060468A3 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
12/04/2003WO2003054017A3 Mono-and dual chemokine/cytokine constructs
12/04/2003WO2003045917B1 Ccr-3 receptor antagonists vii
12/04/2003WO2003032920A3 Oligonucleotide modulation of cell adhesion
12/04/2003WO2003030878A3 Galenic microparticulate oral formulation
12/04/2003WO2003022217A3 Treatment of excessive radiation (e.g. sunburn) exposure
12/04/2003WO2003018019A3 New use of cyclic compounds
12/04/2003WO2003015748A3 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
1 ... 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 ... 1272